New Delhi: The Indian drug regulator has withdrawn the proposal to test Russia’s Coronavirus Vaccine Sputnik-V-COVID-19 (Sputnik-V-COVID-19) in India. In India, Dr. Reddy Laboratories Limited was to undergo a vaccine test. The first small step was to try the vaccine in it. The Central Drugs Standard Control Organization (CDSCO) has issued a notice that in the early-stage study abroad, data on safety and immunity was quite small. There is no input available on Indian participants. Even before the entire trial in India, how Russia’s entire plan has suffered a major setback. The data was to be obtained from the approval of this study for information about the average newly infected.
India may overtake the United States in the next few weeks in terms of maximum corona infects in the world. Experts have expressed such possibilities. Russia’s Direct Investment Fund (RDIF) is marketing this vaccine. This institute partnered with Dr Reddy Laboratories of India last month under clinical trial plan to give vaccine in India.
Russia was the first country to be approved for the Corona virus vaccine. This was done before the trial on a large scale. Doctors and scientists were concerned about its safety and effectiveness. News agency Reuters tried to talk to both partner companies but they refused to respond at the business hours.
Significantly, three vaccines made in India are currently undergoing trials. Serum Institute, Pune has partnered with AstraZeneca for the Oxford COVID 19 vaccine. In this, the second and third phase trials are going on. Bharat Biotech and Jidus Cadila Limited vaccine along with ICMR are in the second phase of human phase.
